Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

Mir-203 Suppresses the Proliferation and Metastasis of Hepatocellular Carcinoma by Targeting Oncogene ADAM9 and Oncogenic Long Non-Coding RNA HULC.

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

HOXD3 Targeted by Mir-203A Suppresses Cell Metastasis and Angiogenesis Through VEGFR in Human Hepatocellular Carcinoma Cells

MiR-875-5p suppresses Gli1 to alter the hedgehog signaling pathway, which in turn has hepatocellular cancer-related tumor suppressing properties

Mir-17-5p and Mir-20A-5p Suppress Postoperative Metastasis of Hepatocellular Carcinoma Via Blocking HGF/ERBB3-NF-κB Positive Feedback Loop

Mir-542-3p Inhibits Metastasis And Epithelial- Mesenchymal Transition Of Hepatocellular Carcinoma By Targeting Ube3c

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Mir-107 Suppresses Proliferation of Hepatoma Cells Through Targeting Hmga2 Mrna 3 ' Utr

Mir-139 Regulates the Proliferation and Invasion of Hepatocellular Carcinoma Through the WNT/TCF-4 Pathway.

Mir-187-3p Inhibits the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Targeting S100A4.

Mir-192, A Prognostic Indicator, Targets the Slc39a6/Snail Pathway to Reduce Tumor Metastasis in Human Hepatocellular Carcinoma

Mir-589-5p Inhibits MAP3K8 and Suppresses CD90+ Cancer Stem Cells in Hepatocellular Carcinoma

MicroRNA-20a Suppresses Tumor Proliferation and Metastasis in Hepatocellular Carcinoma by Directly Targeting EZH1

MicroRNA-195 acts as a tumor suppressor by directly targeting Wnt3a in HepG2 hepatocellular carcinoma cells.

Mir-206 Inhibits Cell Proliferation, Invasion, and Migration by Down-Regulating PTP1B in Hepatocellular Carcinoma.

Mir‐203 Inhibits Augmented Proliferation and Metastasis of Hepatocellular Carcinoma Residual in the Promoted Regenerating Liver

Down-regulation of MAP2K1 by Mir-539 Inhibits Hepatocarcinoma Progression.

Mir-1188 at the Imprinted Dlk1-Dio3 Domain Acts As A Tumor Suppressor in Hepatoma Cells

Long Noncoding RNA Mir503hg, a Prognostic Indicator, Inhibits Tumor Metastasis by Regulating the HNRNPA2B1/NF-κB Pathway in Hepatocellular Carcinoma.

MiR-758-3p Suppresses Proliferation, Migration and Invasion of Hepatocellular Carcinoma Cells Via Targeting MDM2 and Mtor.